In 2019, the Infectious Disease Society of America and American Thoracic Society published updated recommendations for managing patients with community-acquired pneumonia (CAP) generating new considerations for inpatient and outpatient practitioners. This presentation will assess emerging literature influencing the optimal pharmacologic management of CAP such as, changing etiologic trends, patient-specific factors, outcomes evidence, and risk factors for adverse drug reactions. | 1.50 credits (1.50 Pharmacology) | $40

Influenza and COVID-19 are both respiratory illnesses that can cause serious complications, especially in high-risk populations. Nurse practitioners play a key role in the diagnosis and treatment of influenza and COVID-19 infections. This presentation will evaluate the different types of antiviral medications and their pharmacologic features. Patient populations who are most likely to benefit from antiviral therapy will be reviewed. This presentation will examine the most up to date evidence related to efficacy and safety of antivirals for influenza and COVID-19, and provide an approach to the appropriate use of these medications in clinical practice. | 1.50 credits (1.50 Pharmacology) | $40

This lecture will review the general pathophysiology and epidemiology of C.diff and H.pylori and outline at risk populations as well as appropriate diagnostic testing and current management strategies. | 1.50 credits (1.50 Pharmacology) | $40

This lecture will review the general pathophysiology and epidemiology of various liver diseases with a greater focus on liver cirrhosis and associated sequelae including how to approach management of these complications. We will also review pharmacology options in the management of other common chronic liver diseases. | 1.50 credits (1.50 Pharmacology) | $40

This presentation focuses on the practical application of pharmacotherapy for depression in primary care. How to differentiate among SSRIs, and what to do when SSRIs are inadequate or contraindicated. Decisioning pharmacotherapy in the primary care setting and determining when it is appropriate to refer provides a foundation for best practices for the primary care provider. | 1.50 credits (1.50 Pharmacology) | $45

Given the limited access to mental health specialists, primary care practitioners must often diagnose, initiate treatment, and chronically manage different anxiety disorders. This presentation utilizes evidence-based medicine and case studies to discuss the underlying pathophysiology of anxiety and the different options of pharmaceuticals in the treatment of anxiety. | 1.50 credits (1.50 Pharmacology) | $45